Jude
Jude is a technology company.
Financial History
Jude has raised $7.0M across 2 funding rounds.
Frequently Asked Questions
How much funding has Jude raised?
Jude has raised $7.0M in total across 2 funding rounds.
Jude is a technology company.
Jude has raised $7.0M across 2 funding rounds.
Jude has raised $7.0M in total across 2 funding rounds.
Jude has raised $7.0M in total across 2 funding rounds.
Jude's investors include Crane Venture Partners, Eka Ventures, Felix Capital, General Catalyst, Index Ventures, MMC Ventures, Mandeep Singh, AngelList Syndicator, Atomico, Cherry Ventures, Far Out Ventures, Pink Salt Ventures.
Jude refers to multiple entities, but the most prominent technology-aligned company matching the description is Jude, a UK-based startup providing bladder health solutions. This health tech firm develops products focused on bladder health, serving consumers dealing with incontinence and related issues, solving problems like leakage and discomfort through innovative, likely wearable or device-based solutions. It has raised $6.8M in total funding across 2 rounds, with the latest under $5M, indicating strong growth momentum in the health & nutrition sector headquartered in London.[3]
Other "Jude" technology companies include JudeAI (US-based AI platform for real estate agents, helping with leads, marketing, and deals, used by 500+ agents)[4]; Jude Integrated (system integration and business solutions provider)[2]; and Jude Technology, Inc. (IT services in Atlanta)[5]. A Chinese firm, JUDE Technology Co. Ltd., focuses on PVC manufacturing for construction and water treatment, not core tech.[1][6] This analysis centers on the UK bladder health Jude due to its funding traction and tech innovation.
Jude (UK bladder health) emerged as a health tech innovator in the consumer wellness space, headquartered at 15 Bishopsgate, London. Specific founding year and founders are not detailed in available sources, but its development aligns with rising demand for discreet, effective bladder management solutions post-pandemic, drawing $6.8M in funding across two rounds amid notable market interest in manufacturing-adjacent health products.[3] Early traction is evident from revenue under $5M and employee growth, positioning it as a rising player in personalized health devices.[3]
For contrast, JudeAI launched as an AI-first tool tailored for real estate, gaining quick adoption by top agents, while JUDE Technology Co. Ltd. (China) has roots since 1992 in MBBR bio media for wastewater, evolving into PVC products like sheet piles and corner beads.[1][6][4]
In comparison, JudeAI differentiates via AI-driven real estate automation (leads, listings, deals)[4]; Jude Integrated via certifications in system integration and AI maturity assessments[2].
Jude (bladder health) rides the personalized health tech wave, fueled by aging populations, post-COVID wellness focus, and demand for non-invasive incontinence solutions—a market projected to grow amid rising chronic conditions. Timing is ideal with UK health innovation hubs and funding accessibility, bolstered by market forces like telehealth integration and consumer shift to at-home devices.[3] It influences the ecosystem by benchmarking against similar firms in revenue, growth, and funding, highlighting trends in niche medtech for everyday health challenges.[3]
JudeAI taps AI proliferation in proptech, automating agent workflows amid real estate digitization[4], while others like Jude Integrated support business automation maturity.[2]
Jude's bladder health focus positions it for expansion into wearables or app-integrated solutions, leveraging its $6.8M funding for R&D amid AI-enhanced health trends and global incontinence markets. Expect scaling via partnerships, international growth, and acquisitions, evolving influence from niche innovator to ecosystem shaper in consumer medtech—building on its London base and momentum to capture rising demand for dignified health solutions.[3]
Jude has raised $7.0M across 2 funding rounds. Most recently, it raised $4.0M Seed in September 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2023 | $4.0M Seed | Crane Venture Partners, Eka Ventures, Felix Capital, General Catalyst, Index Ventures, MMC Ventures, Mandeep Singh | |
| Mar 1, 2022 | $3.0M Seed | AngelList Syndicator, Atomico, Cherry Ventures, Eka Ventures, Far Out Ventures, General Catalyst, Pink Salt Ventures, #SecretFund, Speedinvest, Vala Capital, Andy Chung, Chris Murphy, Frederic Montagnon, Julien Romanetto, Nicolas Steegmann, Richard Fearn, Thibaud Elziere |